期刊文献+

急性心肌梗死患者治疗前后甲状腺激素水平变化分析 被引量:4

Analysis of change of the serum thyroid hormones level in the patients with acute myocardial infarction before and after treatment
下载PDF
导出
摘要 目的研究甲状腺激素水平在急性心肌梗死(AMI)患者治疗前后的变化情况。方法对82例AMI患者,在治疗前后用ACCESS化学发光仪及配套试剂检测甲状腺激素水平,并对结果进行统计对比分析。结果 AMI患者治疗前甲状腺激素T3、FT3、TSH水平偏低值与治疗后差异有统计学意义(P<0.01)。结论甲状腺激素水平与疾病严重程度及预后有一定的相关性,对AMI诊治和预后评价有一定的临床价值。 Objective To explore the change of the serum thyroid hormones level in the patients with acute myocardial infarction before and after treatment. Methods In 82 patients with acute myocardial infarction, the serum thyroid hormones level were determined by ACCESS chemiluminescence apparatus before and after the treatment, and the results were compared and analyzed. Results In the patients with the acute myocardial infarction, T3 , FT3 , TSH level was low before the treatment and significantly increased after the treatment, there was a remarkable difference be- fore and after the treatment ( all P 〈 0. 01 ). Conclusion The serum thyroid hormones level is relative to the severity of the disease, and the determination of serum thyroid hormones level has certain clinic value for the evaluation of treatment and prognosis of AMI.
出处 《中国临床新医学》 2012年第12期1120-1122,共3页 CHINESE JOURNAL OF NEW CLINICAL MEDICINE
基金 广西卫生厅科研课题(编号:Z2010005) 广西贺州市科学研究与技术开发计划项目课题(编号:贺科转1012004Y)
关键词 甲状腺激素 急性心肌梗死 治疗 Thyroid hormone Acute myocardial infarction Treatment
  • 相关文献

参考文献10

  • 1Vita JA,Gokee N,Duffy SJ,et al. Effect of atorvastatin on endotheli- urn-dependent vasodilation in patients with coronary aa'tery disease [ J ]. Am J Calxtio1,2003,91 (7) : 857 - 860.
  • 2Celermajer DS, Sorensen KE, Gooeh VM, et al. Non-invasive detec- tion of endothelial dysfunction in children and adults at risk of athero- sclerosis [ J ]. Lancet, 1992,340 ( 8828 ) : 1111 - 1115.
  • 3国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(2):75-75.
  • 4Wartofsky L, Burman KD. Alterations in thyroid function in pa-tients with systemic illness:The euthyroid sick syndrome [ J ]. Endocr B_ev, 1982,3(2) :164-217.
  • 5王冬莲,梅丽萍,卢先本,何小帆,廖辉.甲状腺激素水平与冠心病严重程度的相关性研究[J].心脑血管病防治,2009,9(1):9-10. 被引量:8
  • 6杨守方,李明慧,段娜.肺心病心力衰竭患者血清甲状腺激素的变化及临床意义[J].中国医药导报,2009,6(2):60-61. 被引量:2
  • 7Singh S,DuggalJ,Molnaa'J,et al. Im pact of subclinical thyroid disor- ders on coronmy heart disease, cardiovascular and all-cause mol'tality : A meta-analysis [ J ]. Int J Cardio1,2008,125 ( 1 ) :41 - 48.
  • 8Pantos C, Mourouzis I, Markakis K, et al. Thya'oid honnoneatte nuates cardiac remodeling and improves hemodynamics early after acute myo- cardial infarction in rats [ J ]. Eur J Cm-diothorac Surg, 2007,32 (2) : 333 -339.
  • 9Feldt Rasmussen U. Treatment of hypothyroidism in elderly patients and in patients with cardiac disease[ J]. Thyroid,2007,17(7 ) :619 - 624.
  • 10Aguchi T, Iwasaki Y, Asaba K, et al. Myxedema coma and cardia- cischemia in relation to thyroid hormone replacement therapy in a 38-year-old Japanese woman [ J ]. Clin Ther, 2007,29 ( 12 ) : 2710 - 2714.

二级参考文献12

  • 1Pimentel RC, Cardoso GP, Escosteguy CC, et al. Thyroid hormone profile in acute coronary syndromes[J]. Arq Bras Cardiol, 2006, 87(6):688 - 694.
  • 2Vohra HA, Bapu D, Bahrami T, et al. Does periopemtive administration of thyroid hormones improve outcome following coronary artery bypass grafting[J]? J Card Surg, 2008, 23(1):92-96.
  • 3Tendera M. Tae epidemiology of heart failure[J]. J Renin Angiotensin A1- dosterone Syst, 2004, 5 : S2 - S6.
  • 4Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease[J]. Am J Cardiol, 1983, 51(3) :606.
  • 5Sasaki S, Kawai K, Honjo Y, et al. Thyroid hormones and lipid metabolism[J].Ninnon Rinsho. 2006. 64(12):2323- 2323.
  • 6Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular dis ease[J]. Endocrine, 2004, 24(1):1-13.
  • 7Auer J, Berent R, Weber T, et al. Thyroid function is associated with presence and severity of coronary atherosclerosis[J]. Clin Cardiol, 2003, 26(12) :569 - 573.
  • 8Cappola AR, Ladenson PW. Hypothyroidism and athemsclerosis[J]. J Clin Endocrinol Metab, 2003, 88(6) :2438 - 2444.
  • 9Telkova IL, Tepliakov AT. Changes of thyroid hormone levels in the pro- gression of coronary arteriosclerosis[J]. Klin Med (Mosk), 2004, 82(4) : 29-34.
  • 10Mttller B, Tsakiris DA, Roth CB, et al. Haemostatic profile in hypothy- roidism as potential risk factor for vascular or thrombotic disease[J]. Eur J Clin Invest, 2001, 31(2):131 - 137.

共引文献1118

同被引文献20

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部